Projects per year
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Projects
- 1 Finished
-
ANI365: S-adenosyl methionine synthesis as a targetable metabolic vulnerability in Multiple Myeloma
1/11/23 → 31/10/24
Project: Fundamental
-
AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in Acute Myeloid Leukemia
Vandewalle, N., Satilmis, H., Verheye, E., Fan, R., Wang, Y., De Groof, T., Bridoux, J., kerre, T., De Beule, N., De Becker, A., De Bruyne, E., Menu, E., Vanderkerken, K., Breckpot, K., Devoogdt, N. & De Veirman, K., 15 Apr 2024, In: Theranostics. 14, 7, p. 2656-2674 19 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Citation (Scopus)4 Downloads (Pure) -
S-adenosylmethionine biosynthesis is a targetable metabolic vulnerability in multiple myeloma
Wang, Y., Muylaert, C., Wyns, A., Vlummens, P., De Veirman, K., Vanderkerken, K., Zaal, E., Berkers, C., Moreaux, J., De Bruyne, E. & Menu, E., 3 Jan 2024, In: Haematologica. 109, 1, p. 256-271 16 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile5 Citations (Scopus)25 Downloads (Pure) -
The therapeutic potential of targeting the metabolic enzyme MAT2A in multiple myeloma
Wang, Y., 2024, 228 p.Research output: Thesis › PhD Thesis
-
System Xc- inhibition blocks bone marrow-multiple myeloma exosomal crosstalk, thereby countering bortezomib resistance
Wang, F., Oudaert, I., Tu, C., Maes, A., Van der Vreken, A., Vlummens, P., De Bruyne, E., De Veirman, K., Wang, Y., Fan, R., Massie, A., Vanderkerken, K., Shang, P. & Menu, E., Jun 2022, In: Cancer Letters. 535, 215649.Research output: Contribution to journal › Article › peer-review
Open AccessFile18 Citations (Scopus)51 Downloads (Pure) -
ER stress arm XBP1s plays a pivotal role in proteasome inhibition-induced bone formation
Zhang, D., De Veirman, K., Fan, R., Jian, Q., Zhang, Y., Lei, L., Evans, H., Wang, Y., Lei, L., Wang, B., Williamson, R. A., Chantry, A., He, P., Li, A., De Raeve, H., Vanderkerken, K., He, A. & Hu, J., Dec 2020, In: Stem Cell Research & Therapy. 11, 1, 13 p., 516.Research output: Contribution to journal › Article › peer-review
Open Access34 Citations (Scopus)
Prizes
-
S-adenosylmethionine Biosynthesis is a Targetable Metabolic Vulnerability in Multiple Myeloma
Wang, Yanmeng (Recipient) & Menu, Eline (Recipient), 30 Sep 2022
Prize: Prize (including medals and awards)
Activities
- 2 Talk or presentation at a conference
-
AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in Acute Myeloid Leukemia
Niels Vandewalle (Presenter), Hatice Satilmis (Contributor), Emma Verheye (Contributor), Yanmeng Wang (Contributor), Timo De Groof (Contributor), Nathan De Beule (Contributor), Tessa kerre (Contributor), Nathan De Beule (Contributor), Ann De Becker (Contributor), Elke De Bruyne (Contributor), Eline Menu (Contributor), Karin Vanderkerken (Contributor), Karine Breckpot (Contributor), Nick Devoogdt (Contributor) & Kim De Veirman (Contributor)
12 Mar 2024Activity: Talk or presentation › Talk or presentation at a conference
-
S-adenosylmethionine Biosynthesis is a Targetable Metabolic Vulnerability in Multiple Myeloma
Yanmeng Wang (Speaker)
30 Sep 2022Activity: Talk or presentation › Talk or presentation at a conference